Cleared Traditional

K002113 - CTXA HIP (FDA 510(k) Clearance)

Also includes:
CTXA QCT PRO CTXA HIP

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K002113 · Mindways Software, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2001
Decision
545d
Days
Class 2
Risk

K002113 is an FDA 510(k) clearance for the CTXA HIP. Classified as Densitometer, Bone (product code KGI), Class II - Special Controls.

Submitted by Mindways Software, Inc. (San Francisco, US). The FDA issued a Cleared decision on December 4, 2001 after a review of 545 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1170 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Mindways Software, Inc. devices

Submission Details

510(k) Number K002113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2000
Decision Date December 04, 2001
Days to Decision 545 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
438d slower than avg
Panel avg: 107d · This submission: 545d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KGI Densitometer, Bone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1170
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.